CAS | Jotup

AppViewX Named Best DevOps Security Tool Finalist By Computing Magazine

Retrieved on:

Thursday, January 18, 2024

Security, IOT (Internet of Things), Technology, Software, Networks, Internet, Hardware, CAS, Amazon, DevOps, Software as a service, TLS, OpenShift, GKE, AKS, ITSM, Organization, PKI, MIM

AppViewX , the leader in automated machine identity management (MIM) and application security, today announced that AppViewX KUBE+, which simplifies and modernizes certificate lifecycle management for Kubernetes environments, has been shortlisted for Best Devops Security Tool in Computing Magazine’s DevOps Excellence Awards 2024.

Key Points:

AppViewX , the leader in automated machine identity management (MIM) and application security, today announced that AppViewX KUBE+, which simplifies and modernizes certificate lifecycle management for Kubernetes environments, has been shortlisted for Best Devops Security Tool in Computing Magazine’s DevOps Excellence Awards 2024.
Computing's DevOps Excellence Awards showcase outstanding achievements from organizations, personalities and solutions that have successfully applied DevOps methodologies.
AppViewX KUBE+ provides a central solution to discover, manage, automate, control and govern certificates across containerized workloads and Kubernetes infrastructure.
Through holistic visibility, end-to-end automation, and policy control, AppViewX KUBE+ secures containerized workloads at scale while keeping speed and agility intact.

Fannie Mae Prices $819 Million Connecticut Avenue Securities (CAS) REMIC Deal

Retrieved on:

Thursday, January 25, 2024

StoneX Group Inc., CAS, Cantor, Fannie Mae, Nomura, Morgan Stanley, Bank of America, Minority, Disclosure, Wells Fargo, Nomura Securities, News, Bank

Cantor Fitzgerald & Co. ("Cantor") is the co-lead manager and joint bookrunner.

Key Points:

Cantor Fitzgerald & Co. ("Cantor") is the co-lead manager and joint bookrunner.
Co-managers are Morgan Stanley & Co, LLC ("Morgan Stanley"), Nomura Securities International Inc. ("Nomura"), StoneX Financial Inc. ("StoneX"), and Wells Fargo Securities, LLC ("Wells Fargo").
To promote transparency and to help credit investors evaluate our securities and the CAS program, Fannie Mae provides ongoing, robust disclosure data, as well as access to news, resources, and analytics through its credit risk transfer webpages .
In addition to our flagship CAS program, Fannie Mae continues to transfer mortgage credit risk through its Credit Insurance Risk Transfer™ (CIRT™) reinsurance program.

Minister Boissonnault announces over $7 million investment in skilled trades workers in Windsor

Retrieved on:

Wednesday, January 24, 2024

Woman, CAS, Unemployment benefits, Government, Person, Investment, School, Federation, Innovation, Disability, Employment, Workforce, Languages of Ethiopia, Organization, Red Seal, Nursing

Demographic shifts and high retirement rates are fueling demand and an ever-growing need to recruit and train thousands more Canadians in the skilled trades.

Key Points:

Demographic shifts and high retirement rates are fueling demand and an ever-growing need to recruit and train thousands more Canadians in the skilled trades.
In collaboration with unions and employers, the organization will help participants find work placements in the Red Seal trades.
This $7.3 million investment will strengthen our workforce and grow our economy, and support middle class jobs for the people of Windsor."
The Canadian Apprenticeship Strategy (CAS) is a funding program that supports skilled trades workers and employers.

Cascades to Release Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024

Retrieved on:

Monday, January 22, 2024

Conference call, TSX, Conference, CAS

KINGSEY FALLS, QC, Jan. 22, 2024 /PRNewswire/ - Cascades Inc. (TSX: CAS) will release its fourth quarter and full year 2023 financial results before market open on Thursday, February 22, 2024, and will hold a conference call at 9:00 AM ET to discuss results.

Key Points:

KINGSEY FALLS, QC, Jan. 22, 2024 /PRNewswire/ - Cascades Inc. (TSX: CAS) will release its fourth quarter and full year 2023 financial results before market open on Thursday, February 22, 2024, and will hold a conference call at 9:00 AM ET to discuss results.
The Conference call can be accessed by phone or via the Company's website:

Cascades continues to rank among the top 100 most sustainable companies in the world and is first in its industry

Retrieved on:

Wednesday, January 17, 2024

Research, CAS, Hygiene, Toronto Stock Exchange, Recycling, Investment, TSX, Organization, Container, Exercise, Lemaire

Ranking 38th globally, Cascades has maintained it's leading industry position, being named first amongst organizations in the Containers and Packaging sector.

Key Points:

Ranking 38th globally, Cascades has maintained it's leading industry position, being named first amongst organizations in the Containers and Packaging sector.
This recognition highlights the exceptional work of companies such as Cascades that have combined environmental, social and governance considerations with business success.
The analysis used to determine the ranking is based on a methodology that is reviewed annually and takes into account 25 performance indicators.
A total of 6,733 companies across the globe with annual revenues exceeding one billion dollars were evaluated in the most recent exercise.

Cirrus Aircraft Redefines Personal Aviation with SR Series G7 Featuring Touchscreen Displays, New Safety Systems, Premium Travel Amenities and Connected Mobile App

Retrieved on:

Friday, January 12, 2024

The G7 integrates an intuitive touchscreen-controlled flight deck with a comfortable and stylish cabin to create an approachable personal aviation experience.

Key Points:

The G7 integrates an intuitive touchscreen-controlled flight deck with a comfortable and stylish cabin to create an approachable personal aviation experience.
Our aircraft are truly designed with people in mind and the new SR Series G7 is a testament to that philosophy.
"Over the years, Cirrus Aircraft has continuously advanced its product lines while ensuring quality, performance and safety are paramount," said Pat Waddick, President of Innovation and Operations of Cirrus Aircraft.
The SR Series G7 continues to raise the bar as the modern flight training aircraft for forward-thinking, world-class flight training institutions.

Tourmaline Bio Announces Expected Upcoming Key Milestones for the Clinical Development of TOUR006, a Long-Acting Subcutaneous Inhibitor of IL-6 with Best-in-Class Potential, in Thyroid Eye Disease (TED) and Atherosclerotic Cardiovascular Disease (ASCVD)

Retrieved on:

Monday, January 8, 2024

NEW YORK, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Tourmaline Bio, Inc. (Tourmaline) (NASDAQ: TRML), a late-stage clinical biotechnology company developing transformative medicines to dramatically improve the lives of patients with life-altering immune and inflammatory diseases, announced today that:

Key Points:

This second pivotal trial will replace the previously planned TED basket trial and does not impact Tourmaline’s expected cash runway through 2026.
This trial is targeted to commence in the first half of 2024, with topline data expected in the first half of 2025.
Pending success, the results from the Phase 2 trial are expected to position Tourmaline to be ready in 2025 to commence a pivotal Phase 3 trial in cardiovascular disease.
To date, TOUR006 has been studied in 448 participants, including patients with autoimmune disorders, across six clinical trials.

Nicola Mining 2023 Drilling Program at New Craigmont Copper Project Reveals Significant Porphyry-style Alterations

Retrieved on:

Thursday, December 21, 2023

Quartz, National instrument, Database, Anomaly, QA/QC, 1E3, Quality control, Gravity anomaly, News, QC, Digestion, ICP-OES, IP, CRMS, Certified reference materials, CAS, Typesetting

Once complete, Nicola will begin building a 3D geological interpretation using core logs, mapping data and geophysics.

Key Points:

Once complete, Nicola will begin building a 3D geological interpretation using core logs, mapping data and geophysics.
To view an enhanced version of this graphic, please visit:
Mr. Peter Espig, CEO of Nicola Mining Inc., commented on the findings: "Overall the 2023 Program yielded encouraging results.
Nicola maintains tight sample security, and quality assurance and quality control (QA/QC) for all aspects of its exploration program.
Nicola geologists are currently reviewing the results of the QC program, pending lab re-runs of select sample batches.

Affidea Romania Has Acquired Biomed Scan Clinics

Retrieved on:

Saturday, December 2, 2023

Cardiology, MRI, DLA, Acquisition, Lawyer, Patient, CAS, Medical imaging

Bucharest, Romania--(Newsfile Corp. - December 1, 2023) - Affidea Romania, the local subsidiary of the Affidea Group, a European leader in high-performance diagnostic imaging, outpatient services, and treatment, has acquired the Biomed Scan centers in the capital city, thereby reaching a total of 48 multidisciplinary clinics nationwide.

Key Points:

Bucharest, Romania--(Newsfile Corp. - December 1, 2023) - Affidea Romania, the local subsidiary of the Affidea Group, a European leader in high-performance diagnostic imaging, outpatient services, and treatment, has acquired the Biomed Scan centers in the capital city, thereby reaching a total of 48 multidisciplinary clinics nationwide.
Affidea Romania's expansion plan, one of the most important providers of integrated medical services in the domestic market, continues with the acquisition of the two Biomed Scan medical centers - located in the Vitan-Dristor and Titan areas of Sector 3 in the capital.
Biomed Scan offers patients state-of-the-art imaging services: MRI (4 latest generation devices, including one 3Tesla), all types of ultrasounds, as well as specialist consultations (Cardiology, Gastroenterology, Neurology).
The acquisition of Biomed Scan materializes our desire to be present in Sector 3 of the capital, serving important areas with a high concentration of residents," says Răzvan Predica, CEO of Affidea Romania and Hungary.

InspireMD Announces Issuance of Key U.S. Patent Covering Its SwitchGuard™ Neuroprotection System

Retrieved on:

Wednesday, December 20, 2023

NSPR, Bleeding, Risk, Physician, FDA, TCAR, TEL, Blood, Brain, Clinical trial, Stroke, Patent, NPS, IDE, Medicare, Patient, Safety, Stenosis, CAS, CMS, EPS, Pharmaceutical industry

TEL AVIV, Israel and MIAMI, Dec. 20, 2023 (GLOBE NEWSWIRE) -- InspireMD (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) for the prevention of stroke, announced today the issuance of U.S. Patent No.

Key Points:

TEL AVIV, Israel and MIAMI, Dec. 20, 2023 (GLOBE NEWSWIRE) -- InspireMD (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) for the prevention of stroke, announced today the issuance of U.S. Patent No.
11,844,893, titled, “Shunts with Blood Flow Indicators.”
The patent covers key aspects of the company’s SwitchGuard™ Neuroprotection System (NPS) along with future features in development that are expected to enable the treating physician to visualize flow through the system.
The SwitchGuard™ NPS is designed to allow the physician to reverse blood flow to the brain during a carotid artery stenting procedure, including Transcarotid Artery Revascularization (TCAR) or other neurovascular procedures.
The broader availability of these less invasive options should better enable physicians to tailor treatment plans to the needs of individual patients.